Whole Genome Sequence-Based Analyses of Drug Resistance Characteristics, Genetic Diversity, and Transmission Dynamics of Drug-Resistant Mycobacterium tuberculosis in Urumqi City

References

• World Health Organization. Global tuberculosis report 2020. World Health Organization, Geneva 2020. Available from: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2020. Accessed March 19, 2024.
   Google Scholar
• Dheda K, Perumal T, Moultrie H, et al. The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions. Lancet Respir Med. 2022;10(6):603–622. doi:10.1016/S2213-2600(22)00092-3
   PubMed Web of Science ®Google Scholar
• Tiberi S, Vjecha MJ, Zumla A, et al. Accelerating development of new shorter TB treatment regimens in anticipation of a resurgence of multi-drug resistant TB due to the COVID-19 pandemic. Int J Infect Dis. 2021;113(Suppl 1):S96–S99. doi:10.1016/j.ijid.2021.02.067
   PubMedGoogle Scholar
• Tiberi S, Utjesanovic N, Galvin J. Drug resistant TB – latest developments in epidemiology, diagnostics and management. Int J Infect Dis. 2022;124(Suppl 1):S20–S25. doi:10.1016/j.ijid.2022.03.026
   PubMedGoogle Scholar
• World Health Organization. Global tuberculosis report 2022. Geneva: World Health Organization; 2022. Available from: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022. Accessed 22, September 2023.
   Google Scholar
• Eyre DW. Infection prevention and control insights from a decade of pathogen whole-genome sequencing. J Hosp Infect. 2022;122:180–186. doi:10.1016/j.jhin.2022.01.024
   PubMed Web of Science ®Google Scholar
• Nieuwenhuijse DF, van der Linden A, Kohl RHG, Sikkema RS, Koopmans MPG, Oude Munnink BB. Towards reliable whole genome sequencing for outbreak preparedness and response. BMC Genomics. 2022;23(1):569–578. doi:10.1186/s12864-022-08749-5
   PubMed Web of Science ®Google Scholar
• Zheng Y, Zhang X, Wang X, Wang K, Cui Y. Predictive study of tuberculosis incidence by time series method and Elman neural network in Kashgar, China. BMJ Open. 2021;11(1):e041040. doi:10.1136/bmjopen-2020-041040
   PubMed Web of Science ®Google Scholar
• Technical Guidance Group of the Fifth National TB Epidemiological Survey, The Office of the Fifth National TB Epidemiological Survey. The fifth national tuberculosis epidemiological survey in 2010. Chin J Antituberculotic. 2012;34(8):485–508.
   Google Scholar
• Yang JM. Analysis of tuberculosis epidemiological survey conducted in 2010–2011 in Xinjiang Uygur autonomous region. Chin J Antituberculotic. 2013;35(12):960–964.
   Google Scholar
• Chen YangGui CY, Rui BaoLing RB, Chen Ying CY, et al. Survey and analysis of the epidemiology of tuberculosis in Urumqi. Mod Preventive Med. 2013;40(20):3872–3874.
   Google Scholar
• Chen Y. Drug resistance of pulmonary tuberculosis and its influencing factors Urumqi Municipality, 2014. J Pract Prev Med. 2017;24(02):168–171.
   Google Scholar
• Zhang M-W, Zhou L, Zhang Y, et al. Treatment outcomes of patients with multidrug and extensively drug-resistant tuberculosis in Zhejiang, China. Eur J Med Res. 2021;26(1):31–41. doi:10.1186/s40001-021-00502-0
   PubMed Web of Science ®Google Scholar
• Akbar G, Liu Y, Razbek J, et al. Causal effect of the treatment of pulmonary tuberculosis in the elderly based on Bayesian network, Urumqi. J Mod Prev Med. 2020;47(05):788–794.
   Google Scholar
• Tuberculosis Prevention and Control Center of Chinese Center for Disease Control and Prevention. Technical guidelines for tuberculosis prevention and control in China; 2021. Beijin: People’s Medical Publishing House. https://tb.chinacdc.cn/xxjlg/202111/W020211119672904030470.pdf. Accessed March 19, 2024.
   Google Scholar
• Coll F, McNerney R, Afonso Guerra-Assunção J, et al. A robust SNP barcode for typing Mycobacterium tuberculosis complex strains. Nat Commun. 2014;5:4812–4817. doi:10.1038/ncomms5812
   PubMed Web of Science ®Google Scholar
• Wencong H, Tan Y, Liu C, et al. Drug-resistant characteristics, genetic diversity, and transmission dynamics of rifampicin-resistant Mycobacterium tuberculosis in Hunan, China, Revealed by whole-genome sequencing. Microbiol Spectr. 2022;10(1):e0154321–e0154334. doi:10.1128/spectrum.01543-21
   PubMed Web of Science ®Google Scholar
• Okethwangu D, Birungi D, Biribawa C. Multidrug-resistant tuberculosis outbreak associated with poor treatment adherence and delayed treatment: Arua District, Uganda, 2013–2017. BMC Infect Dis. 2019;19(1):387–397. doi:10.1186/s12879-019-4014-3
   PubMed Web of Science ®Google Scholar
• Zhang W, Xing Q, Liu J, et al. Investigation and analysis of drug-resistant tuberculosis in Lintong district from 2017 to 2019. Clin Res Pra. 2023;8(19):32–35. doi:10.19347/j.cnki.2096-1413.202319008
   Google Scholar
• Oladimeji O, Paul Atiba B, Emeka Anyiam F, et al. Gender and drug-resistant tuberculosis in Nigeria. Trop Med Infect Dis. 2023;8(2):104–115. doi:10.3390/tropicalmed8020104
   PubMedGoogle Scholar
• Urumqi Statistics Bureau. Statistical bulletin of Urumqi’s national economic and social development in 2022. Urumqi: Urumqi Statistics Bureau; 2023. https://www.xinjiang.gov.cn/xinjiang/dzdt/202304/abe0ff204835445cb9e0003d646e5f60.shtml. Accessed 22, September 2023.
   Google Scholar
• Leddy AM, Jaganath Rina Triasih D, Triasih R, et al. Social determinants of adherence to treatment for Tuberculosis infection and disease among children, adolescents, and young adults: a narrative review. J Pediatric Infect Dis Soc. 2022;11(Supplement_3):S79–S84. doi:10.1093/jpids/piac058
   PubMed Web of Science ®Google Scholar
• Hulin L, Zhang X, Wang K. A quantitative study on the epidemic situation of tuberculosis based on the transmission disease dynamics in 14 prefectures of Xinjiang from 2005 to 2017. Chin J Infect Cont. 2018;17(11):945–950.
   Google Scholar
• Wang S, Chen R, Chang W, et al. Drug resistance of Mycobacterium tuberculosis in five monitoring sites of Henan Province, 2013–2018. Chin J Infect Control. 2023;22(06):629–636.
   Google Scholar
• Qi Z, Gao X, Wang Y-F, et al. Epidemic characteristics and drug resistance of tuberculosis in North China. Heliyon. 2020;6(9):e04945–e04952. doi:10.1016/j.heliyon.2020.e04945
   PubMed Web of Science ®Google Scholar
• Nasiri MJ, Zamani S, Pormohammad A, et al. The reliability of rifampicin resistance as a proxy for multidrug-resistant tuberculosis: a systematic review of studies from Iran. Eur J Clin Microbiol Infect Dis. 2018;37(1):9–14. doi:10.1007/s10096-017-3079-4
   PubMed Web of Science ®Google Scholar
• Maus CE, Plikaytis BB, Shinnick TM. Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2005;49(8):3192–3197. doi:10.1128/AAC.49.8.3192-3197.2005
   PubMed Web of Science ®Google Scholar
• World Health Organization. Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance. Geneva: World Health Organization; 2021. https://www.who.int/publications/i/item/9789240028173. Accessed February 14, 2024.
   Google Scholar
• Somoskovi A, Helbling P, Deggim V, Hömke R, Ritter C, Böttger EC. Transmission of multidrug-resistant tuberculosis in a low-incidence setting, Switzerland, 2006 to 2012. Euro Surveill. 2014;19(11):20736. doi:10.2807/1560-7917.es2014.19.11.20736
   PubMedGoogle Scholar
• Kant S, Tyagi R. The impact of COVID-19 on tuberculosis: challenges and opportunities. Ther Adv Infect Dis. 2021;8:20499361211016973. doi:10.1177/20499361211016973
   Web of Science ®Google Scholar
• Suzuki TA, Ley RE. The role of the microbiota in human genetic adaptation. Science. 2020;370(6521):eaaz6827–eaaz6837. doi:10.1126/science.aaz6827
   PubMed Web of Science ®Google Scholar
• Dreyer V, Mandal A, Dev P, et al. High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region. Genome Med. 2022;14(1):95. doi:10.1186/s13073-022-01076-0
   PubMed Web of Science ®Google Scholar
• Zhao Y, Xu S, Wang L, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med. 2012;366:2161–2170. doi:10.1056/NEJMoa1108789
   PubMed Web of Science ®Google Scholar